Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection

AIDS Research and Human Retroviruses

Volumn 13, Issue 12, 1997, Pages 1031-1038

  Samuelsson, Astrid ^a   Sönnerborg, Anders ^b   Heuts, Nicole ^a   Cöster, Joakim ^a   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DEATH; CLINICAL ARTICLE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0030753923     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1031     Document Type: Article

References (42)

1. Meyaard L and Miedema F: Programmed death of T cells in HIV infection: Result of immune activation? Curr Top Microbiol Immunol 1995;200:213-221.
2. Graziosi C, Pantaleo G, Gantt KR, et al.: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994;265:248-252.
3. Ameisen JC: Programmed cell death and AIDS: From hypothesis to experiment. Immunol Today 1992;13:388-391.
4. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, and Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992;257:217-219.
5. Groux H, Torpier G, Monté D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
6. Estaquier J, Idziorek T, De Bels F, et al.: Programmed cell death and AIDS: Significance of apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994;91:9431-9435.
7. Itoh N, Yonehara S, Ishii A, et al.: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
8. Trauth BC, Klas C, Peters AM, et al.: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245:301-305.
9. Katsikis PD, Wunderlich ES, Smith CA, and Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995;181:2029-2036.
10. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, and Erb P: The Fas receptor in HIV infection-expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996; 10:9-16.
11. Amadori A, Zamarchi R, Veronese ML, et al.: B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogens. AIDS 1991;5:821-828.
12. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, and Conant M: B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984;251:1447-1449.
13. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, and Fauci AS: Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-458.
14. Kopelman RG and Zolla-Pazner S: Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988;84:82-88.
15. US Department of Health and Human Services: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
16. Fadeel B, Thorpe CJ, and Chiodi F: Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb. Int Immunol 1995;7:1967.
17. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
18. Darzynkiewicz Z, Bruno S, Del Bino G, et al.: Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
19. Hahne M, Renno T, Schroeter M, et al.: Activated B cells express functional Fas ligand. Eur J Immunol 1996;26:721-724.
20. Owen-Schaub LB, Yonehara S, Crump WL III, and Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140:197-205.
21. Lynch DH, Ramsdell F, and Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-574.
22. Carbonari M, Cibati M, Cherchi M, et al.: Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994;83:1268-1277.
23. Pandolfi F, Pierdominici M, Oliva A, et al.: Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J AIDS 1995; 9:450-458.
24. Meyaard L, Otto SA, Keet IP, Roos MT, and Miedema F: Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest 1994; 93:982-988.
25. Berberian L, Valles-Ayoub Y, Sun N, Martinez-Maza O, and Braun J: A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood 1991; 78:175-179.
26. Berberian L, Goodglick L, Kipps TJ, and Braun J: Immunoglobulin VH3 gene products: Natural ligands for HIV gp120. Science 1993; 261:1588-1591.
27. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
28. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995; 373:117-122.
29. Razvi ES and Welsh RM: Apoptosis in viral infections. Adv Virus Res 1995;45:1-60.
30. Livingstone WJ, Moore M, Innes D, Bell JE, and Simmonds P: Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Lancet 1996;348:649-654.
31. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-12690.
32. Wiley SR, Schooley K, Smolak PJ, et al.: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682.
33. Chinnaiyan AM, O'Rourke K, Yu G-L, et al.: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996;274:990-992.
34. Carter RH and Fearon DT: CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256:105-107.
35. Chaouchi N, Vazquez A, Galanaud P, and Leprince C: B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol 1995;154:3096-3104.
36. Suss G and Shortman K: A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183:1789-1796.
37. Badley AD, Mcelhinny JA, Leibson PJ, Lynch DH, Alderson MR, and Paya CV: Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996;70:199-206.
38. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-208.
39. Emini EA, Schleif WA, Nunberg JH, et al.: Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature (London) 1992;355:728-730.
40. Nara PL, Smit L, Dunlop N, et al.: Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol 1990;64:3779-3791.
41. Tremblay M and Wainberg MA: Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J Infect Dis 1990;162:735-737.
42. Albert J, Abrahamsson B, Nagy K, et al.: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990;4:107-112.